Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of Association Between UGT1A1 Polymorphisms and Irinotecan Toxicity in Korean Patients With Advanced Colorectal or Gastric Cancer Treated With FOLFIRI Regimen

NCT01271582 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.

NCT NCT01271582
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01271582 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of Association Between UGT1A1 Polymorphisms and Irinotecan Toxicity in Korean Patients With Advanced Colorectal or Gastric Cancer Treated With FOLFIRI Regimen
Lead sponsor
Asan Medical Center
Phase
Phase 4
Overall status
Unknown status
Start date
January 31, 2009
Completion date
December 31, 2019
Enrollment
1,500 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer, stage iv colorectal cancer